(Q34725611)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12102553%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

review article

1 reference

title

DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12102553%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12102553%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

Viktor Brabec

series ordinal

1

1 reference

4 August 2017

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12102553%20AND%20SRC:MED&resulttype=core&format=json

Progress in Molecular Biology and Translational Science

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12102553%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12102553%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

1-68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12102553%20AND%20SRC:MED&resulttype=core&format=json

Platinum Compounds: a New Class of Potent Antitumour Agents

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Current status of platinum-based antitumor drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Clinical perspectives on platinum resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

1 reference

7 January 2021

Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Superhelical torsion controls DNA interstrand cross-linking by antitumor cis- diamminedichloroplatinum(II)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Biophysical studies of the modification of DNA by antitumour platinum coordination complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Characterization of bifunctional adducts produced in DNA by trans-diamminedichloroplatinum(II)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Intrastrand cross-links are not formed in the reaction between transplatin and native DNA: relation with the clinical inefficiency of transplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Structures of the adducts formed between [Pt(dien)Cl]Cl and DNA in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Evidence from base-pair kinetics for two types of adenine tract structures in solution: their relation to DNA curvature

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Base pair opening pathways in B-DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Structural studies of interactions between anticancer platinum drugs and DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Identification and characterization of a novel linkage isomerization in the reaction of trans-diamminedichloroplatinum(II) with 5'-d(TCTACGCGTTCT)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Linkage isomerization reaction of intrastrand cross-links in trans-diamminedichloroplatinum(II)-modified single-stranded oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Transplatin-modified oligo(2'-O-methyl ribonucleotide)s: a new tool for selective modulation of gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Inhibition of in vitro and ex vivo translation by a transplatin-modified oligo(2'-O-methylribonucleotide) directed against the HIV-1 gag-pol frameshift signal

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

The effect of chromatin structure on cisplatin damage in intact human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

cis- and trans-diamminedichloroplatinum(II) interstrand cross-linking of a defined sequence nucleosomal core particle.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Why does Cisplatin reach Guanine-n7 with competing s-donor ligands available in the cell?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

L-Methionine increases the rate of reaction of 5′-guanosine monophosphate with the anticancer drug cisplatin: mixed-ligand adducts and reversible methionine binding

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Sequence-dependent distortions induced in DNA by monofunctional platinum(II) binding

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Monofunctional adducts of platinum(II) produce in DNA a sequence-dependent local denaturation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

DNA modified by platinum derivatives cannot adopt the A-form

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Bending studies of DNA site-specifically modified by cisplatin, trans-diamminedichloroplatinum(II) and cis-[Pt(NH3)2(N3-cytosine)Cl]+.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Solution structure of a DNA duplex containing a cis-diammineplatinum(II) 1,3-d(GTG) intrastrand cross-link, a major adduct in cells treated with the anticancer drug carboplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Solution structure of a cisplatin-induced DNA interstrand cross-link

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Crystal structure of a double-stranded DNA containing a cisplatin interstrand cross-link at 1.63 A resolution: hydration at the platinated site

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

DNA conformational change produced by the site-specific interstrand cross-link of trans-diamminedichloroplatinum(II)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

NMR solution structure of a DNA dodecamer containing a transplatin interstrand GN7-CN3 cross-link

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Distortions induced in double-stranded oligonucleotides by the binding of cis- or trans-diammine-dichloroplatinum(II) to the d(GTG) sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Sites of termination of in vitro DNA synthesis on cis-diamminedichloroplatinum(II) treated single-stranded DNA: a comparison between E. coli DNA polymerase I and eucaryotic DNA polymerases alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Replication inhibition and translesion synthesis on templates containing site- specifically placed cis-diamminedichloroplatinum(II) DNA adducts

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

An investigation of the sequence-specific interaction of cis-diamminedichloroplatinum(II) and four analogues, including two acridine-tethered complexes, with DNA inside human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

A trans-platinum complex showing higher antitumor activity than the cis congeners

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Interaction of 11 cisplatin analogues with DNA: characteristic pattern of damage with monofunctional analogues.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Mutagenic and genotoxic effects of DNA adducts formed by the anticancer drug cis-diamminedichloroplatinum(II).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

DNA damage in human B cells can induce apoptosis, proceeding from G1/S when p53 is transactivation competent and G2/M when it is transactivation defective.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Transcription by eucaryotic and procaryotic RNA polymerases of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

RNA polymerases react differently at d(ApG) and d(GpG) adducts in DNA modified by cis-diamminedichloroplatinum(II)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Inhibition of RNA Polymerase II Transcription in Human Cell Extracts by Cisplatin DNA Damage

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Spectrum of DNA--platinum adduct recognition by prokaryotic and eukaryotic DNA-dependent RNA polymerases.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

DNA Adducts of cis-Diamminedichloroplatinum(II) and Its Trans Isomer Inhibit RNA Polymerase II Differentially in Vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Cisplatin inhibits synthesis of ribosomal RNA in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Reactions of the UVRABC excision nuclease with DNA damaged by diamminedichloroplatinum(II).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Repair of cisplatin--DNA adducts by the mammalian excision nuclease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Cross-link repair in human cells and its possible defect in Fanconi's anemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Recent insights into platinum drug resistance in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Cisplatin and adriamycin resistance are associated with MutLalpha and mismatch repair deficiency in an ovarian tumor cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Decreased cisplatin damage-dependent DNA synthesis in cellular extracts of mismatch repair deficient cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

In vivo effects of cis- and trans-diamminedichloroplatinum(II) on SV40 chromosomes: differential repair, DNA-protein cross-linking, and inhibition of replication

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Structure and function of the HMGI(Y) family of architectural transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

HMG1 and 2, and related 'architectural' DNA-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

DNA sequence context and protein composition modulate HMG-domain protein recognition of cisplatin-modified DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

HMG-domain protein recognition of cisplatin 1,2-intrastrand d(GpG) cross-links in purine-rich sequence contexts

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

DNA sequence context modulates the impact of a cisplatin 1,2-d(GpG) intrastrand cross-link on the conformational and thermodynamic properties of duplex DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Thermodynamic properties of duplex DNA containing a site-specific d(GpG) intrastrand crosslink formed by an antitumor dinuclear platinum complex

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Two mutations of basic residues within the N-terminus of HMG-1 B domain with different effects on DNA supercoiling and binding to bent DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Relationship of solution and protein-bound structures of DNA duplexes with the major intrastrand cross-link lesions formed on cisplatin binding to DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Interaction of FACT, SSRP1, and the high mobility group (HMG) domain of SSRP1 with DNA damaged by the anticancer drug cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

The general transcription factors of RNA polymerase II

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Cisplatin- and UV-damaged DNA lure the basal transcription factor TFIID/TBP.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

TATA binding protein discriminates between different lesions on DNA, resulting in a transcription decrease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Enhanced binding of the TATA-binding protein to TATA boxes containing flanking cisplatin 1,2-cross-links

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Interaction of histone H1 with cis-platinum modified DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Double-check probing of DNA bending and unwinding by XPA-RPA: an architectural function in DNA repair

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Preferential binding of the xeroderma pigmentosum group A complementing protein to damaged DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

The XPA protein is a zinc metalloprotein with an ability to recognize various kinds of DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Identification of a damaged-DNA binding domain of the XPA protein

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Interactions of mammalian proteins with cisplatin-damaged DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Electrospray ionization-mass spectrometry study of the interaction of cisplatin-adducted oligonucleotides with human XPA minimal binding domain protein

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Binding of XPA and RPA to damaged DNA investigated by fluorescence anisotropy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Human replication protein A preferentially binds cisplatin-damaged duplex DNA in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Replication protein A (RPA) binding to duplex cisplatin-damaged DNA is mediated through the generation of single-stranded DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Selective recognition of a cisplatin-DNA adduct by human mismatch repair proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

The other function of DNA photolyase: stimulation of excision repair of chemical damage to DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Human Ku autoantigen binds cisplatin-damaged DNA but fails to stimulate human DNA-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Cisplatin-DNA adducts inhibit translocation of the Ku subunits of DNA-PK.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

T4 endonuclease VII cleaves DNA containing a cisplatin adduct

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Molecular mechanisms involved in cisplatin cytotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Different recognition of DNA modified by aatitumor cisplatin and its clinically ineffective trans isomer by tumor suppressor protein p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Inhibition of telomerase activity by cisplatin in human testicular cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Inhibition of telomerase activity as a measure of tumor cell killing by cisplatin in squamous cell carcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Platination of the (T2G4)4 telomeric sequence: a structural and cross-linking study.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

In vitro evolution of cisplatin/DNA monoadducts into diadducts is dependent upon superhelical density

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Inhibition of cis-diamminedichloroplatinum (II)-induced DNA interstrand cross-link removal by 7-ethyl-10-hydroxy-camptothecin in HST-1 human squamous-carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Topology effect for DNA structure of cisplatin: topological transformation of cisplatin-closed circular DNA adducts by DNA topoisomerase I

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

cis-Pt(NH3)2Cl2 and trans-Pt(NH3)2Cl2 inhibit DNA synthesis in cultured L1210 leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Is cisplatin-induced cell death always produced by apoptosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Formation of DNA adducts by the anticancer drug carboplatin: different nucleotide sequence preferences in vitro and in cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Increased DNA-binding activity of cis-1,1-cyclobutanedicarboxylatodiammineplatinum(II) (carboplatin) in the presence of nucleophiles and human breast cancer MCF-7 cell cytoplasmic extracts: activation theory revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Displacement of the bidentate malonate ligand from (d,l-trans-1,2-diaminocyclohexane)malonatoplatinum(II)by physiologically important compounds in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Characterization of adducts produced in DNA by isomeric 1,2-diaminocyclohexaneplatinum(II) complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

The Efficiency and Fidelity of Translesion Synthesis past Cisplatin and Oxaliplatin GpG Adducts by Human DNA Polymerase β

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

The effect of DNA structure on the catalytic efficiency and fidelity of human DNA polymerase beta on templates with platinum-DNA adducts

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Antitumor activity of 1,2-diaminocyclohexane--platinum complexes against sarcoma-180 ascites form

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Mutagenic activity of some platinum complexes with monodentate and bidentate amines

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Preparation, characterization, cytotoxicity, and mutagenicity of a pair of enantiomeric platinum(II) complexes with the potential to bind enantioselectively to DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Effect of the diaminocyclohexane carrier ligand on platinum adduct formation, repair, and lethality.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Biological activity of platinum complexes containing chiral centers on the nitrogen or carbon atoms of a chelate diamine ring

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

DNA interactions of antitumor cisplatin analogs containing enantiomeric amine ligands.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

N-(2-chloroethyl)-N-nitrosoureas covalently bound to nonionic and monocationic lexitropsin dipeptides. Synthesis, DNA affinity binding characteristics, and reactions with 32P-end-labeled DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Nonintercalating DNA-binding ligands: specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic material

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

DNA interactions of cisplatin tethered to the DNA minor groove binder distamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Conformational analysis of site-specific DNA cross-links of cisplatin-distamycin conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

DNA interactions of new antitumor aminophosphine platinum(II) complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Does the antitumoral activity of platinum (IV) derivatives result from their in vivo reduction?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Interaction of the antitumor agents cis,cis,trans-PtIV(NH3)2Cl2(OH)2 and cis,cis,trans-PtIV[(CH3)2CHNH2]2Cl2(OH)2 and their reduction products with PM2 DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

DNA binding of iproplatin and its divalent metabolite cis-dichloro-bis-isopropylamine platinum (II)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Detection of DNA strand breaks in Escherichia coli treated with platinum(IV) antitumor compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Octahedral complexes of anti-cancer Pt(IV)(cyclohexyldiamine) agents with 9-methylguanine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

DNA interactions of antitumor platinum(IV) complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

DNA-binding properties of novel cis- and trans platinum-based anticancer agents in 2 human ovarian carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Chemical and biological properties of a new series of cis-diammineplatinum(II) antitumor agents containing three nitrogen donors: cis-[Pt(NH3)2(N-donor)Cl]+

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Monofunctional platinum amine complexes destabilize DNA significantly.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Effects of monofunctional platinum binding on the thermal stability and conformation of a self-complementary 22-mer

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Platinum(II)-Acyclovir Complexes: Synthesis, Antiviral and Antitumour Activity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

DNA interactions of antitumor trans-[PtCl2(NH3)(quinoline)].

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Steric control of DNA interstrand cross-link sites of trans platinum complexes: specificity can be dictated by planar nonleaving groups

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Platinum(II) complexes containing iminoethers: a trans platinum antitumour agent

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

DNA adducts of antitumor trans-[PtCl2 (E-imino ether)2].

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

DNA modifications by antitumor trans-[PtCl2(E-iminoether)2]

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Antitumor Trans Platinum DNA Adducts: NMR and HPLC Study of the Interaction Between a trans-Pt Iminoether Complex and the Deoxy Decamer d(CCTCGCTCTC).d(GAGAGCGAGG).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

X-Ray structure of cytotoxic trans-[PtCl(2)(dimethylamine)(isopropylamine)]: interstrand cross-link efficiency, DNA sequence specificity, and inhibition of the B-Z transition.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Preparation and characterization of novel trans-[PtCl(2)(amine)(isopropylamine)] compounds: cytotoxic activity and apoptosis induction in ras-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Site-specific d(GpG) intrastrand cross-links formed by dinuclear platinum complexes. Bending and NMR studies

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Effect of geometric isomerism in dinuclear platinum antitumour complexes on the rate of formation and structure of intrastrand adducts with oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Effect of geometric isomerism in dinuclear platinum antitumor complexes on DNA interstrand cross-linking

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Sequence specificity, conformation, and recognition by HMG1 protein of major DNA interstrand cross-links of antitumor dinuclear platinum complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

DNA interactions of bifunctional dinuclear platinum(II) antitumor agents

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Sequence specificity of DNA-DNA interstrand cross-link formation by cisplatin and dinuclear platinum complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair of DNA intrastrand cross-links of novel antitumor trinuclear platinum complex BBR3464

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Non-platinum chemotherapeutic metallopharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Modification of natural, double-helical DNA by antitumor cis- and trans-[Cl(2)(Me(2)SO(4))(4)Ru] in cell-free media

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Inhibition of Topoisomerase II Catalytic Activity by Two Ruthenium Compounds: A Ligand-Dependent Mode of Action†

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Biophysical analysis of natural, double-helical DNA modified by anticancer heterocyclic complexes of ruthenium(III) in cell-free media

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Metals and DNA: molecular left-handed complements

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Kinetics and Mechanism of the Oxidation of Sugars and Nucleotides by Oxoruthenium(IV): Model Studies for Predicting Cleavage Patterns in Polymeric DNA and RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Correlation between cytotoxicity and DNA binding of polypyridyl ruthenium complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Homodinuclear (Pt,Pt) and heterodinuclear (Ru,Pt) metal compounds as DNA-protein cross-linking agents: potential suicide DNA lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Effect of cis-platinum(II)diamminodichloride on wild type and deoxyribonucleic acid repair deficient mutants of Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

Proteins that specifically recognize cisplatin-damaged DNA: a clue to anticancer activity of cisplatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

The linker histones and chromatin structure: new twists

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2802%2971040-4

7 January 2021

10.1016/S0079-6603(02)71040-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12102553%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference